FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286294615> ?p ?o ?g. }

• W4286294615 endingPage "8030" @default.
• W4286294615 startingPage "8030" @default.
• W4286294615 abstract "8030 Background: Evaluation of patient (pt)-reported outcomes provides insight into how real-life SOC treatments (tx) affect HRQoL for pts with RRMM. LocoMMotion (NCT04035226) is the first prospective, multinational study of real-life SOC in triple-class exposed pts with RRMM. Here, we present measures of symptoms, functioning, and overall HRQoL. Methods: LocoMMotion is a prospective, noninterventional study across 76 sites (63 European; 13 US). Pts had received ≥3 prior lines of therapy (LOT) or were refractory to PI and IMiD; received PI, IMiD, and anti-CD38 mAb; and had disease progression during/after last LOT. Real-life SOC tx were defined as those used in local clinical practice. The questionnaires were EORTC QLQ-C30, 4 single items from EORTC QLQ-MY20, and EQ 5D-5L. HRQoL was assessed at baseline (BL), day 1 of each tx cycle, end of tx visit, and during the follow-up period (every 4 weeks). Improvement compared to BL health status was evaluated using established thresholds. Within-group change was assessed using mixed models for repeated measures. Results: Questionnaire completion for pts in the LocoMMotion study (N=248; 54.4% male; median age 68 yrs; median 4.0 [range, 1–20] cycles of SOC) was 75.6% during SOC tx. Most pts did not achieve meaningful improvement in PRO scores, defined by a literature-based minimally important difference of 10 points in mean score. This was most pronounced in pain symptoms (62% of pts had no meaningful improvement during the first 3 months of tx; 55% had no improvement during full tx duration). For the overall population, the least square (LS) mean changes from BL during SOC tx and subsequent LOT are described (Table). Pts who achieved very good partial response and better during SOC tx had greater improvement in PRO scores, including in LS mean change for pain score (-14.9 [95% confidence interval (CI): -22.9, -7.0]). Conclusions: In this first prospective study of real-life current SOC in triple-class exposed pts, limited gains in HRQoL were reported, most notably in pain symptoms. There is an urgent need for effective therapies that can help pts achieve deep responses and delay disease progression, as these are associated with improved HRQoL. Clinical trial information: NCT04035226. [Table: see text]" @default.
• W4286294615 created "2022-07-21" @default.
• W4286294615 creator A5001332542 @default.
• W4286294615 creator A5006799794 @default.
• W4286294615 creator A5008759843 @default.
• W4286294615 creator A5012448548 @default.
• W4286294615 creator A5016360607 @default.
• W4286294615 creator A5020524990 @default.
• W4286294615 creator A5022522496 @default.
• W4286294615 creator A5029159537 @default.
• W4286294615 creator A5037293010 @default.
• W4286294615 creator A5040950497 @default.
• W4286294615 creator A5044763057 @default.
• W4286294615 creator A5054304877 @default.
• W4286294615 creator A5060964930 @default.
• W4286294615 creator A5065870295 @default.
• W4286294615 creator A5076452184 @default.
• W4286294615 creator A5078767512 @default.
• W4286294615 creator A5082698003 @default.
• W4286294615 creator A5085068798 @default.
• W4286294615 creator A5086077649 @default.
• W4286294615 creator A5087176280 @default.
• W4286294615 date "2022-06-01" @default.
• W4286294615 modified "2023-10-18" @default.
• W4286294615 title "Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study." @default.
• W4286294615 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.8030" @default.
• W4286294615 hasPublicationYear "2022" @default.
• W4286294615 type Work @default.
• W4286294615 citedByCount "2" @default.
• W4286294615 countsByYear W42862946152022 @default.
• W4286294615 countsByYear W42862946152023 @default.
• W4286294615 crossrefType "journal-article" @default.
• W4286294615 hasAuthorship W4286294615A5001332542 @default.
• W4286294615 hasAuthorship W4286294615A5006799794 @default.
• W4286294615 hasAuthorship W4286294615A5008759843 @default.
• W4286294615 hasAuthorship W4286294615A5012448548 @default.
• W4286294615 hasAuthorship W4286294615A5016360607 @default.
• W4286294615 hasAuthorship W4286294615A5020524990 @default.
• W4286294615 hasAuthorship W4286294615A5022522496 @default.
• W4286294615 hasAuthorship W4286294615A5029159537 @default.
• W4286294615 hasAuthorship W4286294615A5037293010 @default.
• W4286294615 hasAuthorship W4286294615A5040950497 @default.
• W4286294615 hasAuthorship W4286294615A5044763057 @default.
• W4286294615 hasAuthorship W4286294615A5054304877 @default.
• W4286294615 hasAuthorship W4286294615A5060964930 @default.
• W4286294615 hasAuthorship W4286294615A5065870295 @default.
• W4286294615 hasAuthorship W4286294615A5076452184 @default.
• W4286294615 hasAuthorship W4286294615A5078767512 @default.
• W4286294615 hasAuthorship W4286294615A5082698003 @default.
• W4286294615 hasAuthorship W4286294615A5085068798 @default.
• W4286294615 hasAuthorship W4286294615A5086077649 @default.
• W4286294615 hasAuthorship W4286294615A5087176280 @default.
• W4286294615 hasConcept C121332964 @default.
• W4286294615 hasConcept C126322002 @default.
• W4286294615 hasConcept C142424586 @default.
• W4286294615 hasConcept C159110408 @default.
• W4286294615 hasConcept C1862650 @default.
• W4286294615 hasConcept C2779951463 @default.
• W4286294615 hasConcept C71924100 @default.
• W4286294615 hasConcept C87355193 @default.
• W4286294615 hasConceptScore W4286294615C121332964 @default.
• W4286294615 hasConceptScore W4286294615C126322002 @default.
• W4286294615 hasConceptScore W4286294615C142424586 @default.
• W4286294615 hasConceptScore W4286294615C159110408 @default.
• W4286294615 hasConceptScore W4286294615C1862650 @default.
• W4286294615 hasConceptScore W4286294615C2779951463 @default.
• W4286294615 hasConceptScore W4286294615C71924100 @default.
• W4286294615 hasConceptScore W4286294615C87355193 @default.
• W4286294615 hasFunder F4320337415 @default.
• W4286294615 hasIssue "16_suppl" @default.
• W4286294615 hasLocation W42862946151 @default.
• W4286294615 hasOpenAccess W4286294615 @default.
• W4286294615 hasPrimaryLocation W42862946151 @default.
• W4286294615 hasRelatedWork W2068316626 @default.
• W4286294615 hasRelatedWork W2110818089 @default.
• W4286294615 hasRelatedWork W2351796763 @default.
• W4286294615 hasRelatedWork W2351985199 @default.
• W4286294615 hasRelatedWork W2403502999 @default.
• W4286294615 hasRelatedWork W2567738959 @default.
• W4286294615 hasRelatedWork W2923882796 @default.
• W4286294615 hasRelatedWork W2954318774 @default.
• W4286294615 hasRelatedWork W4297834875 @default.
• W4286294615 hasRelatedWork W4366141624 @default.
• W4286294615 hasVolume "40" @default.
• W4286294615 isParatext "false" @default.
• W4286294615 isRetracted "false" @default.
• W4286294615 workType "article" @default.